Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Purpose: Monocyte/HDL cholesterol ratio (MHR) is a novel inflammatory marker that is used as a prognostic factor for cardiovascular diseases and has been studied in many diseases. The aim of this study was to investigate the role of inflammatory factors in schizophrenia patients by examining MHR levels and to compare schizophrenia patients and healthy controls in terms of cardiovascular disease risk. Method: A total of 135 participants between the ages of 18–65, 85 diagnosed with schizophrenia, and 50 healthy individuals in the control group were included in this cross-sectional study. Venous blood samples were taken from the participants and CBC parameters and lipid profiles were analyzed. The sociodemographic and clinical data form and positive and negative symptoms scale (PANSS) were administered to all participants. Results: Although monocyte levels were significantly higher in the patient group, HDL-C levels were lower at significant levels. MHR was found to be higher in the patient group compared to the control group at significant levels. When compared to the control group, total cholesterol, triglyceride, WBC, neutrophil, basophil, and platelet levels were higher in the patient group at significant levels, and RBC, hemoglobin, and hematocrit levels were significantly lower. Conclusion: The elevated MHR in patients with schizophrenia may contribute to our understanding that inflammation plays important roles in the pathophysiology of schizophrenia. Additionally, knowing the levels of MHR and considering the recommendations, such as diet and exercise, in the treatment approaches made us think that it might be beneficial in protecting schizophrenia patients against cardiovascular diseases and early death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MHR in schizophrenia 19,22,68,69 , NHR, PHR and LHR in schizophrenia 19,22 , NLR and MHR in bipolar depression 19,36,37 , MHR in unipolar depression 70 and MHR in post-stroke depression 71 were found higher.”
Citations
Cites
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Second-Generation (Atypical) Antipsychotics and Metabolic Effects: A Comprehensive Literature Review
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,340 · cited 1×
“In other words, this risk increases with the course of the disease and the treatments used [32].”
BackgroundBrain inflammation and adult neurogenesis: The dual role of microglia
Ekdahl, C. T., Kokaia, Z., & Lindvall, O. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.052 · Cited by 801 · cited 1×
“It was reported that microglia, which are the monocytes in the brain, can increase inflammatory activation abnormally, affect neuronal growth factors, or be harmful to neurogenesis and synaptogenesis by producing neurotoxic factors and cytokines [5].”
BackgroundSchizophrenia, “Just the Facts”: What we know in 2008
Tandon, R., Keshavan, M. S., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.022 · Cited by 409 · cited 2×
“In addition, psychiatric diseases and neurological diseases have been detected with artificial intelligence in the literature [1].”
BackgroundBeumer, W., Gibney, S. M., Drexhage, R. C., Pont-Lezica, L., Doorduin, J., Klein, H. C., Steiner, J., Connor, T. J., Harkin, A., Versnel, M. A., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212100 · Cited by 347 · cited 1×
“It was also reported that activation of microglia and circulating monocytes are elevated in schizophrenia patients and in animal models with schizophrenia-like behaviors, which has important effects on the growth, development, and function of neuronal circuits in the brain [6].”
BackgroundMonocyte‐to‐HDL‐cholesterol ratio as a prognostic marker in cardiovascular diseases
Ganjali, S., Gotto, A. M., Ruscica, M., Atkin, S. L., Butler, A. E., Banach, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27028 · Cited by 313 · cited 1×
“According to recent studies, MHR, which is easy to use, non-invasive, and can be obtained with a simple calculation method, was reported to be a prognostic factor in cardiovascular diseases in addition to being a new inflammatory marker [30].”
MethodSerum amyloid A impairs the antiinflammatory properties of HDL
Han, C. Y., Tang, C., Guevara, M. E., Wei, H., Wietecha, T., Shao, B., Subramanian, S., Omer, M., Wang, S., O’Brien, K. D., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83475 · Cited by 171 · cited 2×
“Monocytes and macrophages play important roles in the synthesis and release of pro-inflammatory and prooxidant cytokines [4].”
Aiello, R. J., Brees, D., & Francone, O. L. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000054661.21499.fb · Cited by 146
Negi, G., Kumar, A., Joshi, R. P., & Sharma, S. S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.087 · Cited by 144 · cited 1×
“It is considered today that the MHR may be a new marker of inflammation and oxidative stress because of the anti-inflammatory and antioxidant effects of HDL-C as well as the pro-inflammatory effect of monocytes [12].”
BackgroundWysokiński, A., Strzelecki, D., & Kłoszewska, I. (2015) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2015.04.004 · Cited by 120 · cited 1×
“It was reported in a meta-analysis conducted in schizophrenia patients with first-episode psychosis who did not use medication that HDL-C and total cholesterol ratios were low, and triglyceride ratios were significantly higher [26].”
Result
Research works printed but not linked: 2
- 2021, Comparison of Sleep Quality and Monocyte/High Density Lipoprotein Ratio by Physical Activity Level in Healthy Women, Kırıkkale Üniversitesi Tıp Fakültesi Derg., 23, 522
- First, 1987, Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) New York: Biometrics Research, New York State Psychiatric Institute; 2002, Schizophr Bull., 13, 261
Cited by
Korkmaz, Ş. A., & Kızgın, S. (2023) · Current Medical Research and Opinion · doi:10.1080/03007995.2023.2260302 · Cited by 33
Dudeck, L., Nussbaumer, M., Nickl‐Jockschat, T., Guest, P. C., Dobrowolny, H., Meyer-Lotz, G., Zhao, Z., Jacobs, R., Schiltz, K., Fernandes, B. S., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.4941 · Cited by 31
Nguyen, K. D., Amerio, A., Aguglia, A., Magnani, L., Parise, A., Conio, B., Serafini, G., Amore, M., & Costanza, A. (2023) · Cells · doi:10.3390/cells12162099 · Cited by 14
“Monocytes Increased total monocyte counts [62–64] Increased classical monocyte counts [66] Increased pro-inflammatory monocyte counts [67] Increased monocyte to lymphocyte ratio [68] Increased monocyte to HDL ratio [72,73] Increased TREM1/2 [79,80] Increased ATF3/EGR3 [78] Increased HLA-DR [82] Increased phagocytosis…”
BackgroundChen, L., Zheng, C., Luan, H., & Chen, X. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s473528 · Cited by 10
“24,37 Our study extends these findings by revealing consistent dysregulation of MON counts and HDL levels across different illness stages, showing increased monocytes, HDL, and MHR observed in both AN-FES and CS groups.”
BackgroundNon-diabetic elderly populations: the MHR as a protective factor against bone abnormalities
Li, X., Yan, M., Ji, J., & Ma, Z. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1408467 · Cited by 9
Monocyte-to-HDL cholesterol ratio (MHR) as a novel Indicator of gout risk
Mi, L., He, X., Gao, J., & Xu, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-97373-w · Cited by 6
Róg, J., Karakuła, K. H., Rząd, Z., Niedziałek, K., Juchnowicz, D., Rymuszka, A., & Karakuła‐Juchnowicz, H. (2025) · Nutrients · doi:10.3390/nu17142260 · Cited by 5
“Higher MHR has also been linked to schizophrenia [62], major depressive disorder [63], and bipolar disorder [64].”
Xu, P., Wu, S., Zhao, J., Liu, J., & Zhang, X. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07197-1 · Cited by 5
“For instance, Kılıç et al. found HDL-c levels were significantly reduced while monocyte levels were elevated in schizophrenia patients versus healthy controls [52].”
Muneer, A., Saghir, H., Zahoor, A., Tariq, M., Din, H. U., & Abid, S. (2023) · Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University · doi:10.48036/apims.v19i3.839 · Cited by 3
Korkmaz, Ş. A. (2024) · Ankyra Medical Journal · doi:10.51271/ankmj-0011 · Cited by 1
Nonlinear Association Between Monocyte-to-HDL Ratio and Mortality in COPD: Evidence from NHANES
Tian, T., She, T., Qu, X., & Li, R. (2025) · International Journal of COPD · doi:10.2147/copd.s563173 · Cited by 1
“6,8,13 In this context, our findings further highlight the specific relevance of MHR in the COPD population, where chronic inflammation and lipid metabolism abnormalities coexist and may amplify its prognostic significance.”
Metabolic accompaniment of plasma lipoproteins profile in persons with maladaptation
Tsymbryla, V., Barylyak, L. G., Żukow, X., & Popovych, I. L. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.42.01.016
Kwak, I. H., Ma, H., Kim, Y. J., Noh, H., Lee, J., Yu, J. K., & Kim, Y. E. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251372392 · Cited by 1
Chang, H., Wang, H., Wang, A., Sun, D., Zhao, Z., Ma, D., Lv, H., Wang, S., Guo, J., & Wang, F. (2025) · The Aging Male · doi:10.1080/13685538.2025.2598718 · Cited by 1
“This could potentially make it a more sensitive indicator of systemic processes that impact hormonal health than immune-cell-only indices such as the NLR or platelet-based indices such as the SII [21].”
Chen, S., Liang, J., Li, C., Lin, C., Li, W., He, Z., Fan, F., & Zhang, S. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07842-3
“…pathways, including promoting neuroinflammation, increasing oxidative stress, accelerating neuronal loss, disrupting synaptic pruning mechanisms, and impairing white matter integrity (dysconnection), thereby contributing directly to both cognitive deficits and symptom severity in SCZ [12–14].”
Metadata
- Authors
- Kılıç, N., Tasci, G., Yılmaz, S., Öner, P., & Korkmaz, S.
- Affiliations
- Elazığ Fethi Sekin City Hospital, Department of Psychiatry, Elazığ 23100, Türkiye
- Elazığ Fethi Sekin City Hospital, Department of Microbiology, Elazığ 23100, Türkiye
- Fırat University (TR)
- Venue
- Journal of Personalized Medicine
- Publisher
- MDPI AG
- Published
- 2023-01-31
- Volume
- 13
- Issue
- 2
- Pages
- 276
- ISSN
- 2075-4426 (ISSN-L)
- PMC
- PMC9958934
- OpenAlex
- W4318829874
- Cited by
- 15
- References
- 44
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 3 · 2023: 4
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Personalized Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DSpace - FIRAT (Fırat University) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- schizophrenia, inflammation, inflammatory markers, cardiovascular risk, HDL cholesterol, monocytes, lipid profile, white blood cell count, schizophrenia pathophysiology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
